Short-Term In Vivo Performance of the Cleveland Clinic PediPump Left Ventricular Assist Device

Hideyuki Fumoto, Akira Shiose, Christine R. Flick, Lawrence D. Noble, David T. Dudzinski, Fernando Casas, Tohru Takaseya, Yoko Arakawa, Kiyotaka Fukamachi, William A. Smith, Brian W. Duncan

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The PediPump was implanted in six healthy lambs (mean 25.6±1.4kg) between the left ventricular apex and the descending aorta to evaluate in vivo performance for up to 30 days. Anticoagulation was achieved by continuous heparin infusion. Three animals were euthanized prematurely, two because of respiratory dysfunction and one because of deteriorating pump performance resulting from thrombus formation inside the pump. Three lambs were electively sacrificed 30 days after implantation; all had stable hemodynamics and minimal hemolysis, as indicated by low plasma free hemoglobin (2.5±3.1mg/dL). Mean 30-day pump flow was 1.8±0.1L/min at a pump speed of 12200±400rpm. Neither activated clotting time nor activated partial thromboplastin time followed the changes in heparin dose. At necropsy, depositions were observed at the front (n=1) and rear rotor axial positioning stops (n=4); improved polishing techniques on the stationary stop surfaces and the addition of a hard-carbon, thin-film coating on the rotating stop of the pumps used for the last two experiments addressed the deposition seen earlier. In conclusion, the PediPump showed excellent hydraulic performance and minimal hemolysis during support for up to 30 days. Depositions observed at the axial positioning stops in earlier experiments were addressed by design and material refinements. We continue to focus on developing effective anticoagulation management in the lamb model as well as on further evaluating and demonstrating pump biocompatibility.

Original languageEnglish
Pages (from-to)374-382
Number of pages9
JournalArtificial Organs
Volume38
Issue number5
DOIs
Publication statusPublished - Jan 1 2014

Fingerprint

Left ventricular assist devices
Heart-Assist Devices
Hemolysis
Heparin
Pumps
Partial Thromboplastin Time
Thoracic Aorta
Hemoglobins
Thrombosis
Carbon
Hemodynamics
Hemoglobin
Thromboplastin
Polishing
Biocompatibility
Animals
Rotors
Experiments
Hydraulics
Plasmas

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomaterials
  • Biomedical Engineering

Cite this

Fumoto, H., Shiose, A., Flick, C. R., Noble, L. D., Dudzinski, D. T., Casas, F., ... Duncan, B. W. (2014). Short-Term In Vivo Performance of the Cleveland Clinic PediPump Left Ventricular Assist Device. Artificial Organs, 38(5), 374-382. https://doi.org/10.1111/aor.12179

Short-Term In Vivo Performance of the Cleveland Clinic PediPump Left Ventricular Assist Device. / Fumoto, Hideyuki; Shiose, Akira; Flick, Christine R.; Noble, Lawrence D.; Dudzinski, David T.; Casas, Fernando; Takaseya, Tohru; Arakawa, Yoko; Fukamachi, Kiyotaka; Smith, William A.; Duncan, Brian W.

In: Artificial Organs, Vol. 38, No. 5, 01.01.2014, p. 374-382.

Research output: Contribution to journalArticle

Fumoto, H, Shiose, A, Flick, CR, Noble, LD, Dudzinski, DT, Casas, F, Takaseya, T, Arakawa, Y, Fukamachi, K, Smith, WA & Duncan, BW 2014, 'Short-Term In Vivo Performance of the Cleveland Clinic PediPump Left Ventricular Assist Device', Artificial Organs, vol. 38, no. 5, pp. 374-382. https://doi.org/10.1111/aor.12179
Fumoto, Hideyuki ; Shiose, Akira ; Flick, Christine R. ; Noble, Lawrence D. ; Dudzinski, David T. ; Casas, Fernando ; Takaseya, Tohru ; Arakawa, Yoko ; Fukamachi, Kiyotaka ; Smith, William A. ; Duncan, Brian W. / Short-Term In Vivo Performance of the Cleveland Clinic PediPump Left Ventricular Assist Device. In: Artificial Organs. 2014 ; Vol. 38, No. 5. pp. 374-382.
@article{aaac62404dd3477fb074b12ecea82475,
title = "Short-Term In Vivo Performance of the Cleveland Clinic PediPump Left Ventricular Assist Device",
abstract = "The PediPump was implanted in six healthy lambs (mean 25.6±1.4kg) between the left ventricular apex and the descending aorta to evaluate in vivo performance for up to 30 days. Anticoagulation was achieved by continuous heparin infusion. Three animals were euthanized prematurely, two because of respiratory dysfunction and one because of deteriorating pump performance resulting from thrombus formation inside the pump. Three lambs were electively sacrificed 30 days after implantation; all had stable hemodynamics and minimal hemolysis, as indicated by low plasma free hemoglobin (2.5±3.1mg/dL). Mean 30-day pump flow was 1.8±0.1L/min at a pump speed of 12200±400rpm. Neither activated clotting time nor activated partial thromboplastin time followed the changes in heparin dose. At necropsy, depositions were observed at the front (n=1) and rear rotor axial positioning stops (n=4); improved polishing techniques on the stationary stop surfaces and the addition of a hard-carbon, thin-film coating on the rotating stop of the pumps used for the last two experiments addressed the deposition seen earlier. In conclusion, the PediPump showed excellent hydraulic performance and minimal hemolysis during support for up to 30 days. Depositions observed at the axial positioning stops in earlier experiments were addressed by design and material refinements. We continue to focus on developing effective anticoagulation management in the lamb model as well as on further evaluating and demonstrating pump biocompatibility.",
author = "Hideyuki Fumoto and Akira Shiose and Flick, {Christine R.} and Noble, {Lawrence D.} and Dudzinski, {David T.} and Fernando Casas and Tohru Takaseya and Yoko Arakawa and Kiyotaka Fukamachi and Smith, {William A.} and Duncan, {Brian W.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1111/aor.12179",
language = "English",
volume = "38",
pages = "374--382",
journal = "Artificial Organs",
issn = "0160-564X",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Short-Term In Vivo Performance of the Cleveland Clinic PediPump Left Ventricular Assist Device

AU - Fumoto, Hideyuki

AU - Shiose, Akira

AU - Flick, Christine R.

AU - Noble, Lawrence D.

AU - Dudzinski, David T.

AU - Casas, Fernando

AU - Takaseya, Tohru

AU - Arakawa, Yoko

AU - Fukamachi, Kiyotaka

AU - Smith, William A.

AU - Duncan, Brian W.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The PediPump was implanted in six healthy lambs (mean 25.6±1.4kg) between the left ventricular apex and the descending aorta to evaluate in vivo performance for up to 30 days. Anticoagulation was achieved by continuous heparin infusion. Three animals were euthanized prematurely, two because of respiratory dysfunction and one because of deteriorating pump performance resulting from thrombus formation inside the pump. Three lambs were electively sacrificed 30 days after implantation; all had stable hemodynamics and minimal hemolysis, as indicated by low plasma free hemoglobin (2.5±3.1mg/dL). Mean 30-day pump flow was 1.8±0.1L/min at a pump speed of 12200±400rpm. Neither activated clotting time nor activated partial thromboplastin time followed the changes in heparin dose. At necropsy, depositions were observed at the front (n=1) and rear rotor axial positioning stops (n=4); improved polishing techniques on the stationary stop surfaces and the addition of a hard-carbon, thin-film coating on the rotating stop of the pumps used for the last two experiments addressed the deposition seen earlier. In conclusion, the PediPump showed excellent hydraulic performance and minimal hemolysis during support for up to 30 days. Depositions observed at the axial positioning stops in earlier experiments were addressed by design and material refinements. We continue to focus on developing effective anticoagulation management in the lamb model as well as on further evaluating and demonstrating pump biocompatibility.

AB - The PediPump was implanted in six healthy lambs (mean 25.6±1.4kg) between the left ventricular apex and the descending aorta to evaluate in vivo performance for up to 30 days. Anticoagulation was achieved by continuous heparin infusion. Three animals were euthanized prematurely, two because of respiratory dysfunction and one because of deteriorating pump performance resulting from thrombus formation inside the pump. Three lambs were electively sacrificed 30 days after implantation; all had stable hemodynamics and minimal hemolysis, as indicated by low plasma free hemoglobin (2.5±3.1mg/dL). Mean 30-day pump flow was 1.8±0.1L/min at a pump speed of 12200±400rpm. Neither activated clotting time nor activated partial thromboplastin time followed the changes in heparin dose. At necropsy, depositions were observed at the front (n=1) and rear rotor axial positioning stops (n=4); improved polishing techniques on the stationary stop surfaces and the addition of a hard-carbon, thin-film coating on the rotating stop of the pumps used for the last two experiments addressed the deposition seen earlier. In conclusion, the PediPump showed excellent hydraulic performance and minimal hemolysis during support for up to 30 days. Depositions observed at the axial positioning stops in earlier experiments were addressed by design and material refinements. We continue to focus on developing effective anticoagulation management in the lamb model as well as on further evaluating and demonstrating pump biocompatibility.

UR - http://www.scopus.com/inward/record.url?scp=84899635369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899635369&partnerID=8YFLogxK

U2 - 10.1111/aor.12179

DO - 10.1111/aor.12179

M3 - Article

C2 - 24118024

AN - SCOPUS:84899635369

VL - 38

SP - 374

EP - 382

JO - Artificial Organs

JF - Artificial Organs

SN - 0160-564X

IS - 5

ER -